Duo Oncology
PrivateLast Round
Seed Round
Jun 9, 2026
Total Funding Raised
$9.45M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Duo Oncology is a biotechnology company that develops tumor-responsive nanomedicines to treat difficult-to-target cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Duo Oncology Comparables
Compare Duo Oncology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pendrea Bio, Inc. | 79% | |
| Adcentrx Therapeutics | 73% | |
| Bristol Myers Squibb | 71% |
Duo Oncology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jun 9, 2026 | ||||
| Seed | Aug 7, 2025 | ||||
| Grant | Dec 12, 2024 | ||||
| Accelerator | Mar 21, 2024 | ||||
| Seed | Aug 7, 2023 | ||||
Grant | Apr 17, 2023 |
Key People
Founding team and executive leadership
Duo Oncology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| LifeX Ventures | Seed |
| LifeX Global | Seed |
| Innovation Works | Seed |
| Ulu Ventures | Seed |
| SeedFolio | Seed |
| NuFund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 59% MoM.
- Jun 9, 2026
$1.4M seed round completed.
Recent news
Latest coverage and updates
- receives_financingJul 9, 2026
Duooncology received financing of $1.43M in convertible debt on Jun 1st '26.
Duo Oncology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Duo Oncology's valuation, stock price, and market status.
Is Duo Oncology a public or private company?
Duo Oncology is a private company.
What is the current stock price of Duo Oncology?
Duo Oncology is a private company with no public stock price. No recent secondary market data is available.
How much is Duo Oncology worth (valuation)?
Valuation information for Duo Oncology is not publicly available.
Can I buy Duo Oncology stock?
Duo Oncology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Duo Oncology's last funding round?
Duo Oncology's most recent funding round was Seed Round on June 9, 2026.
Who are the main investors in Duo Oncology?
Key investors in Duo Oncology include SeedFolio.
Will Duo Oncology IPO soon?
No public IPO plans have been announced for Duo Oncology.
How can I track Duo Oncology secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Duo Oncology's secondary market activity and sign up for updates.